Schedule 13G ownership disclosure

Neurogene Inc

Common Stock, $0.000001 par value · CUSIP: 64135M105

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Casdin Capital, LLC

    Shares: 1,295,361.00 · Class: 8.7%

  • Casdin Partners Master Fund, L.P.

    Shares: 1,075,000.00 · Class: 7.2%

  • Casdin Partners GP, LLC

    Shares: 1,075,000.00 · Class: 7.2%

  • Eli Casdin

    Shares: 1,295,361.00 · Class: 8.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-001515
Form type
SCHEDULE 13G/A
Filer
Casdin Capital, LLC
CIK
CIK 1534261
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub